{"title": "C\u00e1ncer de endometrio de riesgo elevado: la quimiorradioterapia complementaria muestra beneficio en la supervivencia sin fracaso en PORTEC-3", "author": "De Boer Sm; Amp; Al", "url": "https://www.univadis.es/viewarticle/cancer-de-endometrio-de-riesgo-elevado-la-quimiorradioterapia-complementaria-muestra-beneficio-en-la-supervivencia-sin-fracaso-en-portec-3", "hostname": "univadis.es", "description": "Los datos en fase III no logran mostrar beneficio en SG frente a la RT p\u00e9lvica por s\u00ed sola.", "sitename": "Clinical Summary", "date": "2018-02-16", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "C\u00e1ncer de endometrio de riesgo elevado: la quimiorradioterapia complementaria muestra beneficio en la supervivencia sin fracaso en PORTEC-3\n- de Boer SM, & al.\n- Lancet Oncol\n- Univadis\n- Clinical Summary\n-\n[El acceso al contenido completo es s\u00f3lo para profesionales sanitarios registrados.](/register?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz) [El acceso al contenido completo es s\u00f3lo para profesionales sanitarios registrados.](/register?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz)\nPunto clave\n- En las mujeres con c\u00e1ncer de endometrio de riesgo elevado (CERE), la quimioterapia complementaria durante y despu\u00e9s de la radioterapia (QRT) mejora de modo significativo la supervivencia sin fracaso (SSF) frente a la RT p\u00e9lvica por s\u00ed sola, pero no influye en ning\u00fan modo sobre la SG.\n- Se observ\u00f3 beneficio significativo en la SSF en las pacientes con c\u00e1ncer en estadio III.\nPor qu\u00e9 es importante\n- Puede sopesarse la QRT para la enfermedad en estadio III para maximizar la SSF despu\u00e9s de sopesar los riesgos en comparaci\u00f3n con los beneficios.\nDise\u00f1o del estudio\n- Ensayo en fase III PORTEC-3 de 660 mujeres con CERE, a las que se asign\u00f3 de modo aleatorio para recibir RT o QRT (2 ciclos de cisplatino durante la RT, seguidos de 4 ciclos de carboplatino-paclitaxel).\n- Se defini\u00f3 como SSF el tiempo transcurrido hasta la primera recidiva o muerte relacionada con el CE o el tratamiento.\n- Financiaci\u00f3n: Sociedad Neerlandesa del C\u00e1ncer; otros.\nResultados clave\n- La SG a los 5 a\u00f1os no difiri\u00f3 entre los grupos (P = 0,109) durante una mediana de seguimiento de 60,2 meses.\n- La QRT se asoci\u00f3 con una tasa de SSF a los 5 a\u00f1os significativamente m\u00e1s elevada en:\n- La poblaci\u00f3n general (75,5 % frente al 68,6 %; HR: 0,71; P = 0,022).\n- Las pacientes con c\u00e1ncer en estadio III (69,3 % frente al 58,0 %; HR: 0,66; P ajustada = 0,014).\n- La tasa de acontecimientos adversos (AA) de grado \u22653 para la QRT en comparaci\u00f3n con la RT fue del 60 % frente al 12 % (P < 0,0001).\n- Los AA hem\u00e1ticos fueron los m\u00e1s frecuentes (45 % frente al 5 %; P < 0,0001).\n- A los 5 a\u00f1os, persist\u00eda la neuropat\u00eda sensorial de grado \u22652 con QRT (9 % frente al 0 %; P < 0,0001).\nLimitaciones\n- Dise\u00f1o abierto.\nHas alcanzdo el l\u00edmite de art\u00edculos por usuarioAcceso gratuito Un servicio exclusivo para profesionales sanitarios\n[\u00bfYa tiene una cuenta? Acceder ahora](https://login.medscape.com/login/sso/getlogin?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz)", "language": null, "image": "/build/images/content/univadis-default-meta.b9dc08b0.png", "pagetype": "article", "links": ["/", "https://login.medscape.com/login/sso/getlogin?wcode=102&client=204204&scode=unies&urlCache=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", "/register?wcode=102&client=204204&scode=unies&urlCache=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", "/reading-list", "/favorites", "/profile?wcode=102&client=204204&scode=unies", "/profile/professional?wcode=102&client=204204&scode=unies", "/account#account_subscriptions", "https://login.medscape.com/login/sso/globallogout?wcode=102&client=204204&scode=unies&urlCache=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", "#", "#", "/news", "/news", "/news/all/alergologia", "/news/all/anestesiologia", "/news/all/cardiologia", "/news/all/cirugia", "/news/all/dermatologia", "/news/all/emergencias", "/news/all/endocrinologia-diabetologia-metabolismo", "/news/all/enf-infecciosas-y-microbiologia", "/news/all/enfermeria", "/news/all/farmacia", "/news/all/gastroenterologia", "/news/all/gerontologia", "/news/all/ginecologia-y-obstetricia", "/news/all/hematologia", "/news/all/inmunologia", "/news/all/medicina-general-familiar", "/news/all/medicina-interna", "/news/all/nefrologia", "/news/all/neumologia", "/news/all/neurologia", "/news/all/obstetricia", "/news/all/oftalmologia", "/news/all/oncologia", "/news/all/otorrinolaringologia", "/news/all/pediatria", "/news/all/psiquiatria", "/news/all/radiologia", "/news/all/reumatologia", "/news/all/traumatologia-y-cirugia-ortopedica", "/news/all/urologia", "/news", "/references", "/education", "/covid-19", "#tab-all", "#tab-news", "#tab-references", "", "/news", "/news/all/alergologia", "/news/all/anestesiologia", "/news/all/cardiologia", "/news/all/cirugia", "/news/all/dermatologia", "/news/all/emergencias", "/news/all/endocrinologia-diabetologia-metabolismo", "/news/all/enf-infecciosas-y-microbiologia", "/news/all/enfermeria", "/news/all/farmacia", "/news/all/gastroenterologia", "/news/all/gerontologia", "/news/all/ginecologia-y-obstetricia", "/news/all/hematologia", "/news/all/inmunologia", "/news/all/medicina-general-familiar", "/news/all/medicina-interna", "/news/all/nefrologia", "/news/all/neumologia", "/news/all/neurologia", "/news/all/obstetricia", "/news/all/oftalmologia", "/news/all/oncologia", "/news/all/otorrinolaringologia", "/news/all/pediatria", "/news/all/psiquiatria", "/news/all/radiologia", "/news/all/reumatologia", "/news/all/traumatologia-y-cirugia-ortopedica", "/news/all/urologia", "/news/topic/antibioticos", "/news/topic/covid-19", "/news/topic/vacunas", "/news/partner/semergen", "http://app.univadis.com/es/", "/register?wcode=102&client=204204&scode=unies&urlCache=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", "https://login.medscape.com/login/sso/getlogin?wcode=102&client=204204&scode=unies&urlCache=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", "/register?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz", "/", "/", "/", "#", "/register?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz", "http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30079-2/abstract", "#tab_reference", "#tab_disclaimer", "/register?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz", "https://login.medscape.com/login/sso/getlogin?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP2lkPTNmOWY1NGM5LTlmYzAtMzFhYy05MWIyLTk2NzM1NmIzMGZjNiZzMT1uZXdz", "https://www.univadis.es/viewarticle/cancer-endometrial-de-riesgo-elevado-la-quimiorradioterapia-complementaria-prolonga-la-supervivencia?id=6f3713c6-10d5-3b27-a529-de7c3764f721&s1=news", "https://www.univadis.es/viewarticle/cancer-de-endometrio-la-quimiorradioterapia-complementaria-fracasa-en-la-faseiii?id=e826a5a2-982b-33e2-9946-c49ec0c478c0&s1=news", "https://www.univadis.es/viewarticle/cancer-de-endometrio-de-riesgo-elevado-la-quimiorradioterapia-complementaria-supera-a-la-radioterapia-en-cuanto-a-la-supervivencia-sin-progresion-a-los-5anos-y-la-supervivencia-especifica-al-cancer?id=6077b554-1455-3bb9-82e7-225f089113ec&s1=news", "https://www.univadis.es/viewarticle/cancer-endometrial-de-riesgo-elevado-la-quimiorradioterapia-complementaria-prolonga-la-supervivencia?id=6f3713c6-10d5-3b27-a529-de7c3764f721&s1=news", "https://www.univadis.es/viewarticle/cancer-de-endometrio-la-quimiorradioterapia-complementaria-fracasa-en-la-faseiii?id=e826a5a2-982b-33e2-9946-c49ec0c478c0&s1=news", "https://www.univadis.es/viewarticle/cancer-de-endometrio-de-riesgo-elevado-la-quimiorradioterapia-complementaria-supera-a-la-radioterapia-en-cuanto-a-la-supervivencia-sin-progresion-a-los-5anos-y-la-supervivencia-especifica-al-cancer?id=6077b554-1455-3bb9-82e7-225f089113ec&s1=news", "/viewarticle/hay-relaci%25C3%25B3n-entre-el-tratamiento-hormonal-para-la-2023a1000lph", "/viewarticle/el-tratamiento-conjunto-con-f%25C3%25A1rmacos-antinflamatorios-2023a1000lvl", "/viewarticle/dos-opciones-similares-para-personas-mayores-con-enfermedad-2023a1000lvj", "/viewarticle/s/%25C3%2581cido-acetilsalic%25C3%25ADlico-reduce-riesgo-de-diabetes-2023a1000lf6", "/viewarticle/alcohol-y-efectos-sobre-la-tensi%25C3%25B3n-arterial-2023a1000lo7", "/viewarticle/el-pembrolizumab-perioperatorio-es-prometedor-para-el-2023a1000lvd", "/viewarticle/gu%25C3%25AD-para-el-manejo-cl%25C3%25ADnico-de-pacientes-con-covid-2023a1000mgl", "/viewarticle/la-infertilidad-masculina-vinculada-la-morbilidad-y-la-2023a1000lv7", "/education/challenges/arteriopatia-vertebral-cuales-son-las-estrategias-de-obtencion-de-imagenes-recomendadas-af5904ea-0c82-4769-bdc0-343a144c30b8/f062a5c1-ca3c-429d-9a30-0f640bf086b6", "/education/challenges/que-eficacia-presenta-el-paracetamol-contra-la-lumbalgia-aguda-af5904ea-0c82-4769-bdc0-343a144c30b8/5d4e4919-d304-4ee6-a3d5-95c002832d20", "/page/about-us", "/page/editorial-policy", "/page/who-we-are", "/page/terms-of-use", "/page/privacy-policy", "/page/cookie-notice", "#", "https://univadises.onelink.me/BPLZ?pid=Univadis&c=Footer", "http://m.onelink.me/8022dfa5", "http://m.onelink.me/350d48e9", "https://help.univadis.es", "mailto:info@univadis.es", "/page/terms-of-use/1.1", "% ppUrl%", "mailto:privacy@aptushealth.com", "/page/terms-of-use", "/page/privacy-policy", "mailto:privacy@aptushealth.com", "/register?wcode=102&client=204204&scode=unies&urlCache=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", "https://login.medscape.com/login/sso/getlogin?wcode=102&client=204204&scode=unies&urlCache=aHR0cHM6Ly93d3cudW5pdmFkaXMuZXMvdmlld2FydGljbGUvY2FuY2VyLWRlLWVuZG9tZXRyaW8tZGUtcmllc2dvLWVsZXZhZG8tbGEtcXVpbWlvcnJhZGlvdGVyYXBpYS1jb21wbGVtZW50YXJpYS1tdWVzdHJhLWJlbmVmaWNpby1lbi1sYS1zdXBlcnZpdmVuY2lhLXNpbi1mcmFjYXNvLWVuLXBvcnRlYy0zP3Rva2VuPVJnSndyJTJGZkdubEVydmoxSUNkJTJCcGVzNUFnam5IaGJ5MHNySnU1TzlQSUx0ODFOTVhiNXR3U2lrME1qSHlEaUVkWCUyQk1vUEJlJTJGJTJCMm0lMkZJYUJPJTJCJTJGMHNSY2hEckN1bFJja3pvdEZZblk2U3pvWWVFUDVPYjZwelN4NUw0M1dKR01KY0ZMQWZiWVVpRlZXNjh1blFWWk10a1FmaG9KbDRaRWxzQ1BrbzZCV08lMkJ2bXUwd0dYRVlmM3hQVU1NMWZaQ2tYNENQeGRYMlRaREdwN0dVaTR4U2pQRmh3S3JkZEN3Tk1JTjRmbFV4YlU0Vkhpa3RsanRYTHBQRnlMaWt6TnN3b25CRG01VENnSE1MOXIxUDYlMkJJYUJZVnV1cGY1TGhhUDVXQW43TXFNUjNnakJlb2hTS3JqNVhBajBUJTJGSFMlMkJwTDg5aDRrc0NBdHBvdUFFa0l6c3BCNmlQVFQzS2poSUZOJTJGaFRlWDRBUWpYNUlDTlI1ekZjZGpnalhJUTBSY2pKYVV3TmltYTVjQmQ3QnlMM3VmbTJDOVR4aDRQVnZIOEcwYXhwNHdOT0FyV3JZQSUzRA"]}